DAY 0 - Pre-Conference
Industry Tour: Inside the NextGen Biologics Plant Experience a guided visit to one of Europe’s most advanced biologics manufacturing facilities, exploring process automation, quality systems, and capacity expansion strategies. |
DAY 1
Opening Remarks: Europe’s Next Leap in Antibody Innovation
Antibody Engineering & Therapeutics: The Next European Frontier: Talks on where antibody innovation is heading from modularity to multispecifics to AI designed scaffolds. |
Refreshments & Networking Break |
Antibody Clinical Insights: Lessons from Europe’s Leading Trials |
Lunch & Poster Exhibition |
Designing for Manufacturability: Bringing Complex Antibodies to GMP Reality How European biotech and CDMOs are rethinking cost per gram and expanding manufacturing in emerging regions Democratising Antibody Therapeutics: Reducing Cost & Expanding Access |
Refreshments & Networking Break |
Roundtable Discussions:
|
Cocktail Reception & The NextGen Biologics Awards |
End of Day 1 |
DAY 2
Economics: How European Biotechs & CDMOs Are Rethinking Cost Per Gram Discussions on new economic models, process intensification, and regional capacity expansion from Western Europe to emerging manufacturing hubs. |
Refreshments & Networking Break |
Manufacturing & Scale-Up of Complex Antibody Modalities Lessons from scaling antibodies and antibody-like formats |
Lunch & Poster Exhibition |
Joint Session Across All Co-Located Events: AOCs & POCs |
Refreshments & Networking Break |
Joint Session Across All Co-Located Events: 2035 Outlook: Smart Factories & Predictive Controls How smart factories, digital process controls, and predictive analytics are transforming Antibody and Oligonucleotide Conference Chair Wrap-Up |
End of Day 2 |
*Please note that this is a working agenda and is subject to change
